Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SGLT2-inhibitors Reduce the Cardiac Autonomic Neuropathy Dysfunction and Vaso-vagal Syncope Recurrence in Patients With Type 2 Diabetes Mellitus: the SCAN Study

NCT03717207 is registered in ClinicalTrials.gov with University of Campania Luigi Vanvitelli as lead sponsor.

NCT NCT03717207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03717207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SGLT2-inhibitors Reduce the Cardiac Autonomic Neuropathy Dysfunction and Vaso-vagal Syncope Recurrence in Patients With Type 2 Diabetes Mellitus: the SCAN Study
Lead sponsor
University of Campania Luigi Vanvitelli
Phase
Observational
Overall status
Completed
Start date
January 1, 2010
Completion date
March 1, 2021
Enrollment
242 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

syncope, vasovagal